PharOS is a privately owned pharmaceutical company, developing, manufacturing and supplying generics and value added products with a global portfolio of more than 113 products and over 10.308 marketing authorizations worldwide.

PharOS is a multi-disciplinary organization, in recognition of the numerous different knowledge sets that are required for a proper pharmaceutical product development, registration and supply. Our expertise covers all aspects of product development from API sourcing up to market release.

At PharOS, we have a highly skilled workforce of more than 413 professionals all focused on developing and placing in the market top quality generic and other value added pharmaceuticals that improve the lives of patients to more than 119 countries.